Literature DB >> 24049547

Role of stereotactic biopsy in histological diagnosis of multiple brain lesions.

Ali Meshkini1, Sohrab Shahzadi, Hossein Alikhah, Mohammad Naghavi-Behzad.   

Abstract

BACKGROUND AND AIM: The current advances in diagnostic and therapeutic modalities and increasing in survival of patients with systemic diseases and immunosuppressive cases have caused to increasing frequency and variety of Central Nervous System neuropathologic processes indicating the necessary need for accurate localization of space-occupying lesions by cytology and histology. This study was aimed to evaluate the usefulness and safety of stereotactic biopsy in histological diagnosis of such lesions.
MATERIALS AND METHODS: Of 2081 patients underwent stereotactic biopsy of brain lesions using Riechert-Mundinger system, 158 had multifocal brain lesions, and were enrolled.
RESULTS: The ages of studied cases were ranged from 2 years to 75 years (Mean age: 41.3 year), 114 were male and 44 were females. Incidence of histopathologic diagnosis of multifocal brain lesions included Astrocytoma grade II (41.3%), Astrocytoma grade I (12.9%), glioblastoma multiform (11.1%), Astrocytoma grade III (10.2%), malignant lymphoma (10.2%), metastasis (4.6%), pilocytic Astrocytoma (2.7%), abscess (2.7%), craniopharyngioma (1.8%) vascular malformations (0.9%), and tuberculosis (0.9%). Mortality due to operation is none.
CONCLUSIONS: Histopathologic diagnosis of multiple brain lesions is necessary for decision of appropriate management and stereotactic biopsy of brain lesion is a useful and safe method for histological diagnosis.

Entities:  

Keywords:  Biopsy; brain; lesion; multifocal; stereotactic

Year:  2013        PMID: 24049547      PMCID: PMC3775184          DOI: 10.4103/1793-5482.116374

Source DB:  PubMed          Journal:  Asian J Neurosurg


Introduction

Now a days, the number of detections related to various brain lesions has increased using computed tomography (CT) scan and magnetic resonance imaging (MRI) for diagnosis of patients suffering from neurological focal deficiency or symptoms of increasing intracranial pressure or even for patients with slighter symptoms.[1234] Furthermore, advances in the therapeutic methods and increasing number of survival in patients with systematic diseases, resulted in the developing of metastatic into the central nervous system or high incidence of CNS infections, which are partly due to high confrontation with immune system deficiency (due to Acquired Immunodeficiency Syndrome (AIDS) or following immunosuppressive treatment in the recipients of transplantation or in patients under chemotherapy for systematic cancer); diversity and the number of CNS neuro-pathologies has increased requiring the needs for the more accurate detailed differential diagnosis of histology and cytology of cerebral space-occupying lesions (SOLs).[12356789] However, in most of the patients, it is possible to show nature of their brain lesion, accurately through clinical and laboratory findings. Examples are multiple sclerosis, secondary infectious and parasite diseases, metastatic tumors and brain involvement of systemic disease. However, in some cases, numerous brain lesions that are diagnosed in CT scan or MRI are the only provable documents for the disease and a proper therapy designing depends on the histological diagnosis.[345101112131415] The main purpose of this paper is to show the benefits of stereotactic methods for diagnosing the nature of these lesions.

Materials and Methods

This is a retrospective study performed on 2081 patients undergone stereotactic biopsy of brain lesions since 1989 until 2007, amongst them, 158 patients have had multiple brain lesions. The patients were selected for stereotactic biopsy, based on the following criteria: An undiagnosed intra-axial mass lesion that could not be approved by standard craniotomy without undue risk of morbidity Invasive lesions without significant mass effect Poorly defined lesions on CT or MRI An intracranial lesion in a patient whose general medical status precluded craniotomy A condition for which medical therapy would likely be superior to operative resection (e.g., multiple lesions) Differentiating between tumor recurrence and radio-necrosis Suspicion of lesions with significant radio-sensitivity such as lymphomas and germinoma Lesions which are highly susceptible to non-neoplastic origin such as infections and demyelinating lesions; and Patients with poor general medical conditions who could not tolerate general anesthesia and major surgery. There were 114 male (72.2%) and 44 female patients (27.8%). The mean age of patients was 41.3 ± 15.9 years (range of 2-75 year). The most prevalent age period of disease was the fifth decade. According to accessibility to imaging tools and facilities, the patients underwent CT scan (with and without contrast), or MRI (with and without contrast). Furthermore, in some rare cases for the better judgment of lesions both methods were used. Multiple brain lesions were considered as two or more discrete lesions in multiple cerebral lobes, multi loculated lesions in multiple lobes, such as craniopharyngioma and diffuse involvement of brain in multiple lobes as seen in glioma. The number of the lesions was two or more. Fifty two patients had right hemisphere lesions and 86 had left hemisphere lesions and 20 had lesions in both hemispheres. All of the stereotactic biopsies were conducted using Riechert-Mundinger system and all of the samples were taken using biopsy needle and aspiration. No case of mortality was found.

Results

Histological diagnosis of lesions is summarized in Table 1. More than one fifth of the patients had multifocal malignant gliomas, including astrocytoma anaplastic (10.2%) and multiform glioblastoma (11.1%). More than half of the patients had low grade multifocal gliomas, and majority of them were distributed lesions that involved adjacent lobes. Numerous points of them had undergone enhancement so appeared as numerous multifocal lesions. Furthermore, 10.2% of the patients had malignant lymphoma, which have not responded to pre-operative corticosteroid. Of all patients, 4.6% had metastatic tumor, which didn’t have any symptoms of primary tumor in any other part of their bodies prior to the biopsy. Furthermore, 2.7% of the patients had multiple brain abscesses with whom the intra abscess pus drainage was conducted beside the biopsy of abscess wall in order to help improvement of patients’ clinical and neurological condition. There were some cases of the tuberculoma and multifocal vascular lesions in which the diagnosis was made only by brain biopsy despite performing several pre-operative analyses. Furthermore, 1.8% of cases had craniopharyngioma, where evacuation of cyst fluid, putting a reservoir for next drainages, and applying radioactive phosphorus were conducted in addition to tissue diagnosis.
Table 1

Histological diagnoses in 158 patients with multiple lesions made by stereotactic biopsy

Histological diagnoses in 158 patients with multiple lesions made by stereotactic biopsy

Discussion

A vast range of diseases in this series of patients emphasize on the importance of lesion histology in order to avoid the risks of therapies based on the clinical and imaging data. Stereotactic biopsy with low morbidity and without mortality would fulfill this goal. In the analysis of Franzini et al., among 940 patients, 100 (10.6%) of them had multiple lesions including 37% malignant gliomas, 15% primary lymphoma, 15% brain metastases, 12% low grade gliomas, 10% infectious disease (including brain abscess and viral multifocal encephalitis) and 6% ischemic lesions, and others had rare lesions.[16] In the study of Calisaneller et al., from 100 stereotactic biopsies, 4.25% of the cases were multiple[10] In the analysis of Shahzadi et al., 7.6% (22 of 288 cases) of thalamic lesion biopsies showed bilateral lesions, and in the study of Zali et al., 67% of (n = 90) cerebral lymphoma biopsies, revealed multiple lesions.[1718] In our study, 10.1% of sampled lesions were multiple and the histologic diagnoses, according to their prevalence, were as following: Grade II astrocytoma, grade I astrocytoma, glioblastoma multiform, grade III astrocytoma, malignant lymphoma, metastases [Figure 1], astrocytoma pilocytic, abscess, craniopharyngioma, Vascular lesions (angiopathy), [Figure 2], tuberculosis and very rare cases of multiple sclerosis [Figure 3] and Systemic juvenile xanthogranuloma [Figure 4].
Figure 1

Metastatic adenocarcinoma (case 1)

Figure 2

Hemorrhagic locoencephalopathy (Vascular lesions (angiopathy)) (case 2)

Figure 3

Multiple sclerosis (case 3)

Figure 4

Systemic juvenile xanthogranuloma (case 4)

Metastatic adenocarcinoma (case 1) Hemorrhagic locoencephalopathy (Vascular lesions (angiopathy)) (case 2) Multiple sclerosis (case 3) Systemic juvenile xanthogranuloma (case 4) Authors reported multiple cranial lesions (n = 7) in 172 pediatric cases with intracranial lesions who underwent stereotactic biopsy,[19] and in other study we reported a case of systemic juvenile xanthogranoloma with multiple central nervous system lesions [Figure 4].[20] Furthermore, in a study about stereotactic biopsy of brain stem lesions we reported a large number of patients with multiple lesions involving brain stem that histopathologic examinations revealed glioblastoma multiform anaplastic astrocytoma, lymphoma, abscess, adenocarcinoma, and multiple sclerosis.[21] Therefore, patients with multiple cerebral space-occupying lesions can be categorized into two groups: Patients without previous history of tumor who had multiple SOLs: These patients should be analyzed thoroughly since, they are suspected to have malignancy in other parts of their bodies. However, screening is a time consuming process and missing the primary tumor is not unusual. Furthermore, previous immunosuppressive treatments (e.g., transplant recipients) or immune deficiency syndromes (e.g., AIDS) could lead to opportunistic infections in the brain (e.g., Aspergillus, Toxoplasmosis) or even secondary brain tumors (malignant lymphoma). Furthermore, lesions that are permitted to be treated rarely by open surgery, since, they are multiple, are preferable not to be treated with surgery. Then, stereotactic biopsy of one or two of these lesions should be conducted, in order to help oncologists to know the tissue properties of lesion (e.g., Squamous cell carcinoma, Adenocarcinoma, and lymphoma). At the same time, microbiologic studies begin in order to diagnose possible infectious diseases Patients with known primary tumor in other parts of their bodies and multiple cerebral SOLs without another metastatic spread. Any further, therapy must be decided based on of patient's condition and features of the primary tumor. If the usefulness of radiotherapy, chemotherapy, or both be considered, metastases should be confirmed histologically because of decision making difficulty for both patient and doctor. However, as it mentioned before, diagnosed SOLs could have non-tumoral nature. Differentiation between metastatic and non-neoplastic tissues can be easily obtained by stereotactic biopsy which is a relative indication in these conditions.

Conclusions

Multiple cerebral lesions can face any surgeon with a serious problem. First, it is important to be assured that these lesions are tumors not inflammatory foci (such as multiple sclerosis and acquired immune deficiency syndrome). Secondly, it seems that the absence of a known tumor out of the brain is an indication to get at least one tissue diagnosis, even when a tumor could be resected with craniotomy. Biopsy is suggested as a first step, which helps patients to overcome their mental stress, and it also make it possible to design the next therapy area (eventually surgery). When multiple tumors in a patient with primary tumor are being diagnosed, the value of biopsy is highly dependent on history and prognosis. If the possibility of definite cure is desirable and if the intracranial metastases will change the consequent treatment regimen, then biopsy could have an enormous importance.
  19 in total

1.  Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements.

Authors:  L S Hu; L C Baxter; K A Smith; B G Feuerstein; J P Karis; J M Eschbacher; S W Coons; P Nakaji; R F Yeh; J Debbins; J E Heiserman
Journal:  AJNR Am J Neuroradiol       Date:  2008-12-04       Impact factor: 3.825

2.  The accuracy and diagnostic yield of computerized tomography guided stereotactic biopsy in brain lesions.

Authors:  Tarkan Calişaneller; Ozgür Ozdemir; Ozkan Ozger; Ozlem Ozen; Halil Kiyici; Hakan Caner; Nur Altinörs
Journal:  Turk Neurosurg       Date:  2008-01       Impact factor: 1.003

3.  Progressive multifocal leukoencephalopathy in an HTLV-I carrier.

Authors:  Akiko Kimura; Hidetsugu Ueyama; Noriyuki Kimura; Shin Fujimoto; Toshihide Kumamoto
Journal:  Clin Neurol Neurosurg       Date:  2005-10-27       Impact factor: 1.876

4.  Clinical validation of true frameless stereotactic biopsy: analysis of the first 125 consecutive cases.

Authors:  T S Paleologos; N L Dorward; J P Wadley; D G Thomas
Journal:  Neurosurgery       Date:  2001-10       Impact factor: 4.654

5.  Systemic juvenile xanthogranuloma with multiple central nervous system lesions.

Authors:  Ali Meshkini; Sohrab Shahzadi; Alireza Zali; Aram Tajeddini; Javad Mirzayan; Amir Hamdi
Journal:  J Cancer Res Ther       Date:  2012 Apr-Jun       Impact factor: 1.805

6.  [Peritumoral hemorrhage immediately after radiosurgery for metastatic brain tumor].

Authors:  Masafumi Uchino; Satoru Kitajima; Chikao Miyazaki; Takashi Otsuka; Yoshikatsu Seiki; Iekado Shibata
Journal:  No Shinkei Geka       Date:  2003-08

Review 7.  [Functional imaging in brain tumors].

Authors:  Katalin Borbély
Journal:  Orv Hetil       Date:  2004-02-22       Impact factor: 0.540

8.  Multicentric glioblastoma multiforme determined by positron emission tomography: a case report.

Authors:  Ajay Jawahar; Christina Weilbaecher; Cedric Shorter; Nancy Stout; Anil Nanda
Journal:  Clin Neurol Neurosurg       Date:  2003-12       Impact factor: 1.876

9.  5-Aminolevulinic acid-induced protoporphyrin IX fluorescence as immediate intraoperative indicator to improve the safety of malignant or high-grade brain tumor diagnosis in frameless stereotactic biopsies.

Authors:  Gord von Campe; Michael Moschopulos; Martin Hefti
Journal:  Acta Neurochir (Wien)       Date:  2012-04       Impact factor: 2.216

10.  Stereotactic co-registration of magnetic resonance imaging and histopathology in post-mortem multiple sclerosis brain.

Authors:  K Schmierer; F Scaravilli; G J Barker; R Gordon; D G MacManus; D H Miller
Journal:  Neuropathol Appl Neurobiol       Date:  2003-12       Impact factor: 8.090

View more
  5 in total

1.  Opportunistic Disease or Metastatic Lesions: A Rare Finding in a Patient with Bladder Cancer.

Authors:  Michael Simon; Natalie Elkayam; Jonathan Smerling; Michael Marcelin; Stephan Kamholz
Journal:  Curr Urol       Date:  2019-09-10

2.  Morphological Patterns of Intracranial Lesions in a Tertiary Care Hospital in North Karnataka: A Clinicopathological and Immunohistochemical Study.

Authors:  Neelakantaiah Anadure Hema; Ramdurg Shashank Ravindra; Andola Sainath Karnappa
Journal:  J Clin Diagn Res       Date:  2016-08-01

Review 3.  Global morbidity and mortality of central nervous system tuberculosis: a systematic review and meta-analysis.

Authors:  Alba Navarro-Flores; Jose Ernesto Fernandez-Chinguel; Niels Pacheco-Barrios; David R Soriano-Moreno; Kevin Pacheco-Barrios
Journal:  J Neurol       Date:  2022-03-15       Impact factor: 4.849

4.  Atypical medulloblastoma: A case series.

Authors:  Ali Meshkini; Amir Vahedi; Mohammad Meshkini; Hossein Alikhah; Mohammad Naghavi-Behzad
Journal:  Asian J Neurosurg       Date:  2014-01

5.  Characterisation of Severe Traumatic Brain Injury Severity from Fresh Cerebral Biopsy of Living Patients: An Immunohistochemical Study.

Authors:  Ping K Yip; Shumaila Hasan; Zhuo-Hao Liu; Christopher E G Uff
Journal:  Biomedicines       Date:  2022-02-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.